Crestor (Rosuvastatin) is a statin drug used to lower cholesterol and triglycerides in the blood. It lowers LDL ( buildup of fat in the blood ) and triglycerides while triglycerides remain high cholesterol. This medicine also lowers the risk of cardiovascular complications including heart attack, stroke and blood clots.
Crestor was approved by the FDA in 2003. Rosuvastatin is used to lower cholesterol and triglycerides in the blood. Lowering these cholesterol and triglycerides and reducing the risk of cardiovascular complications reduces the risk of endometrial cancer, a type of cancer that can occur in the ovaries, throat and chest.
Crestor is also used to treat high blood pressure. High blood pressure often occurs in people with a history of heart disease, and Crestor can lower blood pressure. Lowering high blood pressure and lowering blood pressure reduces the risk of stroke and heart attack, as well as certain types of cancer. Crestor is also used to lower the risk of kidney stones, an infection caused by a bacteria that is found in kidney stones.
Crestor’s Mechanism of Action
Crestor is a member of a class of drugs called statins. It works by blocking the action of an enzyme called HMG-CoA reductase, which converts some of the cholesterol found in the blood to make cholesterol. Rosuvastatin lowers the amount of this enzyme by inhibiting it.
Rosuvastatin is the active ingredient in Crestor and Rosuvastatin Crestor.
Crestor (Rosuvastatin) is taken orally once daily in the morning. Crestor is also available as a generic medicine.Learn more about CrestorThis product may expire and other information can be found on the manufacturer website at.
Ingredients
Rosuvastatin includes:
• Calcium carbonate, anhydrous; • Hypromellose • Sodium hydroxide, sodium carbonate, or magnesium stearate • Iron oxide • Yellow iron oxide • Yellow silica gelCrestor and rosuvastatin may interact with each other. Crestor and rosuvastatin should not be taken together, as they can cause serious and fatal interactions.More interactionscan occur with some other medications. If you are taking any of these medications, tell your doctor before you start taking rosuvastatin.Serious interactionscan occur with Crestor and rosuvastatin. If you have any of these medications that can cause serious interactions, or if you have a history of these conditions, tell your doctor right away. These conditions may need treatment with Crestor or rosuvastatin.Endometriosiscan occur in the ovaries. If you have endometriosis, tell your doctor right away. This disease can affect a woman's ability to have normal menstrual cycles and may require treatment with Crestor.Other interactionscan occur with other medications. Tell your doctor if you are taking any of the following medications:,,,,,,,, or.If you have any questions about this medicine, tell your doctor right away. This medicine can affect the way other medicines work, and this medicine can affect the way other medicines work. This medicine can also affect how other medicines work. This medicine can also affect the way other medicines work. Make sure you tell your doctor before you take this medicine, as certain medicines can change the effect of this medicine. Make sure your doctor knows about your medical history before you take this medicine. Tell your doctor if you or a family member has any thoughts or reactions to this medicine. Your doctor may need to change the dose of this medicine in patients with diabetes and may need to change the strength of the medicine in patients with kidney disease.
Crestor (Rosuvastatin) may cause liver problems. Tell your doctor if you have any liver problems. This medicine can also cause side effects. Tell your doctor if you are being treated for any other medicines, as they can affect the way other medicines work. Tell your doctor if you are being treated for any of these other medicines:Medicines that can affect the way other medicines work.Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$12.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Keep out of the reach of childrenAs with any prescription, there is a required information sheet to be followed. Please post the product's product information on to your web-commissioning reader within the aware email address.ratings.co.uk. All trademarks and registered trademarks are the property of their respective owners. Please do not contact us if you have any questions.
Medicare registry number 102832. healthylife.com.au. Product registry number 102832. Medicines supplied by Healthylife: Crestor - Prescription Only (20mg) $9.95 For prescription only (20mg) $13.95 Qiao SiohuaProduct information
Healthylife is supplied by Bijelpharm Ltd, a registered pharmacy chain in Hong Kong. The pharmacy consists of three primary operating divisions: Healthylife, a division of Bijelpharm Ltd, and PharmaHealth. The third division, Healthylife, is responsible for the supplying of medications to patients in the three main therapeutic areas: oncology, immunology, and rheumatology. The remaining three divisions operate in the areas of pharmaceutical supply, distribution, and supply chain management. Healthylife is a registered trademark of Healthylife.
Healthylife contains 20mg of Rosuvastatin as its active ingredient. Rosuvastatin is a cholesterol-lowering medicine used to treat hyperlipidemia and other related diseases. Rosuvastatin is a prescription-only medication used to lower levels of LDL (low-density lipoprotein) cholesterol in the blood. It is prescribed for the treatment of patients with high blood cholesterol levels and also for the prevention of heart attacks and strokes. Rosuvastatin is available in the form of tablets, capsules, syrup, and liquid suspension. It is used to lower LDL cholesterol levels by reducing the absorption of cholesterol from the blood and increasing the level of cholesterol in the blood. It is also used to treat high blood triglyceride levels and to prevent or reduce high blood pressure in patients with high triglyceride levels. Rosuvastatin is a prescription-only medicine used to treat hyperlipidemia and other related diseases.
Medicare registry number 117777. Healthylife.com.au. Product registry number 117777. Product information on this page is for guidance only. It is not a substitute for professional medical advice, diagnosis or treatment.Medicare registry number 102836. Product registry number 102836. Medicines supplied by Healthylife: Crestor - Prescription Only (20mg) $13.95 For prescription only (20mg) $13.95Medicare registry number 102838. Product registry number 102838.Medicare registry number 102839. Product registry number 102839.Medicare registry number 110892. Product registry number 110892.Medicare registry number 100010.AstraZeneca has agreed to pay $3.5 billion to settle allegations it illegally promoted and sold certain drugs, including Crestor, for the treatment of heart and lipid disorders, according to a news release.
The payments, which have been made between July 2013 and April 2014, were part of an agreement reached in an internal agreement between AstraZeneca and two companies that would have the potential to further increase drug sales for the treatment of heart and lipid disorders.
The agreements, which were signed by AstraZeneca, include payments of $6.4 billion, $1.3 billion, and $1.1 billion in settlement amounts, according to the documents and information provided by the companies.
“The settlement agreements are important milestones for AstraZeneca in the ongoing litigation over the use of Crestor and the potential for a successful future trial in the class action,” said Richard Evans, senior vice president for global litigation, AstraZeneca.
“We are pleased that our company has reached an agreement with AstraZeneca to pay $3.5 billion to settle the ongoing litigation. These payments will allow us to expand the market for Crestor, and hopefully, will allow us to continue to manufacture, market, and sell Crestor at a significant price,” he added.
The company said the agreements were entered into in the course of an ongoing relationship, which is not expected to be disclosed in the settlement agreements. The agreements are expected to be submitted to the court later this year.
The company said it is working with AstraZeneca on a new treatment to reduce heart and lipid disorders.
“We are pleased that our company has entered into an agreement with AstraZeneca to pay $3.5 billion to settle the ongoing litigation of a number of other class action settlements,” said Richard Evans, senior vice president for global litigation, AstraZeneca.
AstraZeneca is seeking $1.3 billion in compensation from the company for the conduct of its civil settlement with the class action plaintiffs, including its attorneys, which include lawyers who had a part in the settlement. The settlement agreement is expected to be submitted to the court later this year.
AstraZeneca said it has agreed to pay $1.2 billion in cash and other payments for the litigation, including payments of $5.8 billion and $5.8 billion, to the plaintiffs who allege that the company violated the settlement agreement by marketing, selling, or offering for sale of certain drugs for the treatment of heart and lipid disorders.
The settlement will allow the parties to file a separate class action lawsuit to resolve the allegations of the settlements with the plaintiffs.
“This agreement is a significant milestone for our company in the ongoing litigation of our class action suit and in the future,” Evans added.
The company said it has also agreed to pay $1.6 billion to settle claims brought by the plaintiffs that the company violated the settlement agreement and that it violated the terms of the agreement by promoting and selling certain drugs for the treatment of heart and lipid disorders. The agreement was signed by AstraZeneca and its partner, Eli Lilly, in the context of the settlement.
The settlement agreements have been in effect since at least July 2014.
The settlement is expected to be submitted to the court later this year.
The following are related articles. These include articles that appeared in print at The New York Times.
ReferencesAstraZeneca and Bristol-Myers Squibb had the right to launch a product that would be the first treatment of heart and lipid disorders that would be approved by the Food and Drug Administration.
Acarbose belongs to a group of medicines called ‘sucralfate' called a "selective beta-adrenergic antagonist" which was developed in the 1950s. It was rejected by the US government after a trial showed it had an effect similar to that of angiotensin converting enzyme (ACE) inhibitors. However, it was rejected by the US Food and Drug Administration (FDA) due to safety concerns. The drug is now only prescribed to patients with heart failure, and is used to treat angina. Acarbose is a very dangerous drug. It can cause serious blood clots in the heart and blood vessels of the lungs, as well as causing stroke in some people. The risk of stroke is increased in people with high blood pressure or those with a history of stroke. High blood pressure is a risk factor for stroke and heart disease. High blood pressure is a condition of the heart's ability to pump blood and therefore the risk of stroke is increased. This risk is increased in people with a history of high blood pressure. High blood pressure is also known as hypertension or high blood pressure in the arteries of the lungs.
Crestor belongs to a group of medicines called "yrimethamine". It is used to lower cholesterol levels in people who have been on a low-fat diet for some time and to reduce the risk of heart attack and stroke. Crestor works by blocking the action of a particular enzyme called type II 5-alpha reductase and prevents the production of cholesterol. Crestor is available only by prescription. It can only be obtained with a valid prescription from your doctor and is not effective for the treatment of cholesterol.
Crestor is used to treat high cholesterol levels in people who have been on a high-fat diet for some time. This can be done by reducing the amount of fat in foods such as, but not limited to, fried foods. Crestor is also used to treat high blood pressure in people who have a history of heart attack or stroke.
Crestor is used to treat diabetes in people who have high blood sugar levels. It is also used to treat high cholesterol levels in people who have a history of high blood cholesterol levels. Crestor can also be used to treat high blood pressure in people who have a history of high blood pressure. Crestor may cause serious side effects such as chest pain and swelling, rapid heart rate, or fainting. The risk of these side effects is increased in people who take an ACE inhibitor. The risk of cardiovascular events increases in people who take an ACE inhibitor.
Crestor is usually taken once a day with meals. You may take it on an empty stomach, with a light meal or with a high-fat meal. The dose may be increased as necessary. You can take Crestor on an empty stomach or with a high-fat meal. You may take Crestor with or without food. You can take Crestor with or without food.
Stade de France Pharmacy